RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maarit Tiirikainen to Prognosis

This is a "connection" page, showing publications Maarit Tiirikainen has written about Prognosis.
Connection Strength

0.260
  1. Tiirikainen MI, Mullaney BP, Holly EA, Pallavicini MG, Jensen RH. DNA copy number alterations in HIV-positive and HIV-negative patients with diffuse large-cell lymphomas. J Acquir Immune Defic Syndr. 2001 Jul 01; 27(3):272-6.
    View in: PubMed
    Score: 0.042
  2. Fu Y, Katsaros D, Biglia N, Wang Z, Pagano I, Tius M, Tiirikainen M, Rosser C, Yang H, Yu H. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/?-catenin pathway and associates with favorable prognosis of ovarian cancer. Sci Rep. 2021 04 05; 11(1):7484.
    View in: PubMed
    Score: 0.042
  3. Shiosaki J, Tiirikainen M, Peplowska K, Shaeffer D, Machida M, Sakamoto K, Takahashi M, Kojima K, Machi J, Bryant-Greenwood P, Kuwada SK. Serum micro-RNA Identifies Early Stage Colorectal Cancer in a Multi-Ethnic Population. Asian Pac J Cancer Prev. 2020 Oct 01; 21(10):3019-3026.
    View in: PubMed
    Score: 0.040
  4. Wang Z, Katsaros D, Biglia N, Shen Y, Fu Y, Tiirikainen M, Yu H. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome. FEBS Open Bio. 2019 07; 9(7):1270-1280.
    View in: PubMed
    Score: 0.037
  5. Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, Yu H, Tiirikainen M, Fogelgren B, Fan R, Garmire LX. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis. EBioMedicine. 2016 May; 7:62-72.
    View in: PubMed
    Score: 0.029
  6. Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, Yang H, Carbone M. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015 Apr; 10(4):565-76.
    View in: PubMed
    Score: 0.027
  7. Tiirikainen MI, Elonen E, Ruutu T, Jansson SE, Krusius T. Clinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry. Eur J Haematol. 1993 May; 50(5):279-85.
    View in: PubMed
    Score: 0.024
  8. Kanerva J, Tiirikainen MI, M?kipernaa A, Riikonen P, M?tt?nen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up. Pediatr Hematol Oncol. 2001 Jan-Feb; 18(1):27-36.
    View in: PubMed
    Score: 0.010
  9. Kanerva J, Tiirikainen M, M?kipernaa A, Riikonen P, M?tt?nen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL. Pediatr Hematol Oncol. 1998 Jan-Feb; 15(1):11-21.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support